1
Home
Companies

SI-BONE

#6428

Rank

$586.7M

Marketcap

US United States

Country

SI-BONE
Leadership team

Ms. Laura A. Francis MBA (CEO & Director)

Mr. Anshul Maheshwari (Chief Financial Officer)

Mr. Anthony J. Recupero (Pres of Commercial Operations)

Products/ Services
Health Care, Health Diagnostics, Hospital
Number of Employees
100 - 500
Headquarters
San Jose, California, United States
Established
2008
Company Registration
SEC CIK number: 0001459839
Revenue
20M - 100M
Traded as
SIBN
Social Media
URL
https://si-bone.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
History

SI-BONE Inc. was founded in 2007 by two surgeons, Jeff Ross and Perry Karsen, with the goal of providing minimally invasive solutions for the treatment of spine disorders associated with the sacroiliac joint. The company’s first product was the iFuse Implant System, which was launched in the United States in 2008 and is now available in more than 80 countries. Initially developed for sacroiliac joint fusion, the iFuse Implant System has evolved to include indications for degenerative sacroiliac joint disruption and ankylosing spondylitis, and is now the most comprehensive system for treating sacroiliac joint disorders.

Mission
Our mission is to leverage our medical technology and expertise to develop innovative, minimally invasive therapies designed to improve the quality of life of patients suffering from spine disorders.
Vision
Our vision is to create a world of painless movement where spine disorders are no longer a burden to patients.
Key Team

Mr. Michael A. Pisetsky (Sr. VP of Operations & Admin., Sec. and Chief Legal Officer)

Mr. Jeff Bertolini (Sr. VP of Operations & Information Technology)

Dr. Scott A. Yerby (Sr. VP of Engineering & CTO)

Mr. Joseph W. Powers (VP of Corp. Marketing)

Ms. Aimee Einstein (VP of People & Culture)

Dr. Daniel Joseph Cher (Sr. VP of Clinical & Regulatory Affairs)

Dr. W. Carlton Reckling (Chief Medical Officer & VP of Medical Affairs)

Recognition and Awards
SI-BONE has been the recipient of numerous awards, including the 2015 Best Spine Implant Company of the Year and the 2016 MedTech Breakthrough Awards Best Spine Technology Company of the Year.
References

https://in.investing.com/equities/si-bone-inc

https://www.comparably.com/companies/si-bone/mission

https://www.crunchbase.com/organization/si-bone

https://finance.yahoo.com/quote/SIBN/

https://si-bone.com

https://sec.report/CIK/0001459839

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

SI-BONE
Leadership team

Ms. Laura A. Francis MBA (CEO & Director)

Mr. Anshul Maheshwari (Chief Financial Officer)

Mr. Anthony J. Recupero (Pres of Commercial Operations)

Products/ Services
Health Care, Health Diagnostics, Hospital
Number of Employees
100 - 500
Headquarters
San Jose, California, United States
Established
2008
Company Registration
SEC CIK number: 0001459839
Revenue
20M - 100M
Traded as
SIBN
Social Media
URL
https://si-bone.com